Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-10

FDA Approved: CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE — Original Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a generic topical product containing ciprofloxacin hydrochloride and hydrocortisone under an original application for Cosette Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin hydrochloride and hydrocortisone (Ciprofloxacin hydrochloride and hydrocortisone)

Snippet

ORIG AP for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE (CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE)